Impel Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Impel Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1794% to $12,652,000. Profit margin reached -1023%. Total operating expenses were $89,341,000.
Profit Margin
| 2019 | 0 | -41.85M | |
|---|---|---|---|
| 2020 | 0 | -45.79M | |
| 2021 | 668K | -76.53M | -11457.49% |
| 2022 | 12.65M | -129.44M | -1023.08% |
IMPL Income Statement (2019 – 2022)
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 12.65M | 668K | 0 | 0 |
Cost of revenue | 6.49M | 691K | 0 | 0 |
Gross profit | 6.15M | -23K | 0 | 0 |
Operating exp. | ||||
Research and development | 11.45M | 20.56M | 27.28M | 28.81M |
Selling and marketing | 7.6M | 12.6M | 0 | 0 |
Total operating expenses | 89.34M | 71.46M | 45.33M | 41.56M |
Operating income | -83.18M | -71.48M | -45.33M | -41.56M |
Other income (expenses), net | -23.12M | -5.04M | -463K | -263K |
Income before tax | -106.31M | -76.53M | -45.79M | -41.82M |
Income tax expense | 23.12M | 2K | 1K | 30K |
Net income | -129.44M | -76.53M | -45.79M | -41.85M |
Earnings per share | ||||
Basic EPS | -5.52 | -5.24 | -3.49 | -3.19 |
Diluted EPS | -5.52 | -5.24 | -3.49 | -3.19 |
| Data source | Data source |